Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden.
Cell Transplant. 2012;21(1):333-43. doi: 10.3727/096368911X576036. Epub 2011 Jun 7.
Stem cell transplantation procedures using intraparenchymal injections cause tissue injury in addition to associated surgical risks. Intravenous cell administration give engraftment in parenchymal lesions although the method has low efficacy and specificity. In pathological conditions with inflammation, such as traumatic brain injury, there is a transient up-regulation of ICAM-1 and VCAM-1 which might provide environmental cues for migration of stem cells from blood to parenchyma. The aim of this study was to i) analyze the effect of intra-arterial administration on cellular engraftment, ii) compare engraftment and side effects between three different stem cell systems, and iii) analyze gene expression in these three systems. We performed specific intra-arterial transplantations with human mesenchymal stem cells (hMSCs), human neural progenitor cells (hNPCs), and rat neural progenitor cells (rNPCs) in a rat model of traumatic brain injury. These results were compared to the intravenous route for each cell type, respectively. Analysis of engraftment and recipient characterization was performed by immunohistochemistry. We further characterized the different types of cells by microarray and RT-qPCR analysis. Specific intra-arterial transplantations produced significantly higher engraftment compared to intravenous transplantation with hMSCs and rNPCs. No engraftment was detected after intra-arterial or intravenous administration of hNPCs. Characterization of integrin expression indicated that CD49dVCAM-1 and possibly ICAM-1 interactions through CD18 and CD11a, respectively, are important for engraftment after intravascular cell administration. No side effects, such as thromboembolic complications, were detected. When translating stem cell therapies to clinical practice, the route of transplantation and the properties of the cell lines (homing, diapedesis, and migration) become important. This study supports the use of selective intra-arterial transplantation for improving engraftment after traumatic brain injury. In addition, we conclude that careful analysis of cells intended for local, intra-arterial transplantation with respect to integrin expression is important.
经皮注射的干细胞移植程序除了相关的手术风险外,还会造成组织损伤。静脉内细胞给药可使实质病变中出现嵌合体,但该方法的效率和特异性均较低。在炎症性病理条件下,如创伤性脑损伤,ICAM-1 和 VCAM-1 的表达一过性上调,这可能为干细胞从血液迁移到实质提供环境线索。本研究的目的是:i)分析动脉内给药对细胞移植的影响;ii)比较三种不同干细胞系统的移植效果和副作用;iii)分析这三种系统中的基因表达。我们在创伤性脑损伤大鼠模型中进行了特定的动脉内移植,分别使用人骨髓间充质干细胞(hMSCs)、人神经祖细胞(hNPCs)和大鼠神经祖细胞(rNPCs)。将这些结果与每种细胞类型的静脉途径进行了比较。通过免疫组织化学分析对移植效果和受体特征进行了评估。我们进一步通过微阵列和 RT-qPCR 分析对不同类型的细胞进行了特征描述。与静脉内移植 hMSCs 和 rNPCs 相比,特定的动脉内移植可显著提高移植效果。静脉内或动脉内给予 hNPCs 后均未检测到移植效果。整合素表达的特征表明,CD49d-VCAM-1 和可能分别通过 CD18 和 CD11a 的 ICAM-1 相互作用,对于血管内细胞给药后的移植效果很重要。未检测到血栓栓塞等副作用。在将干细胞疗法转化为临床实践时,移植途径和细胞系的特性(归巢、透壁和迁移)变得很重要。本研究支持使用选择性动脉内移植来提高创伤性脑损伤后的移植效果。此外,我们得出结论,对于拟用于局部、动脉内移植的细胞,整合素表达的仔细分析很重要。